Navegar por autor "Álvarez Gómez, Elena"

Mostrando ítems 1-6 de 6

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

2011- Antolín Novoa, Silvia; García Mata, Jesús; Álvarez Gómez, Elena; Mel Lorenzo, José Ramón; De Paz Arias , Laura [et al.]
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

2013- Candamio Folgar, Sonia; Gallardo Martín , Maria Elena; Campos Balea, Begoña; Álvarez Gómez, Elena; Quintero Aldana, Guillermo; [et al.]
Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; Mel Lorenzo, José Ramón [et al.]
Final analysis of dose density with zoledronic acid treatment in metastatic breast cancer patients: ZARAS study

2011- Álvarez Gómez, Elena; Fernández Pérez, Isaura
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer

2015- Gallardo Martín , Maria Elena; Fernández Montes, Ana; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; [et al.]
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment

2012- Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Álvarez Gómez, Elena; Quintero Aldana, Guillermo; [et al.]